COVER STORY: Global Biotech Report
Buisness Facilities Contributed Content
APRIL 22, 2013
About 56 percent of all biotech companies in Hessen have their own R&D programs. CEO Dr. Steven Davis told the San Antonio Business Journal late last year (when the company began raising the round) that it would fund research projects to validate the quality of the stem cells generated by the company’s technology.
63 
Let's personalize your content